Addressing the Challenges of Tuberculosis: A Brief Historical Account

Tuberculosis (TB) is a highly contagious disease that still poses a threat to human health. Mycobacterium tuberculosis (MTB), the pathogen responsible for TB, uses diverse ways in order to survive in a variety of host lesions and to subsequently evade immune surveillance; as a result, fighting TB an...

Full description

Bibliographic Details
Main Authors: Hussam W. Al-Humadi, Rafal J. Al-Saigh, Ahmed W. Al-Humadi
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-09-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00689/full
id doaj-df1f0dea33a8440a8d45fbcd08f22c8b
record_format Article
spelling doaj-df1f0dea33a8440a8d45fbcd08f22c8b2020-11-24T22:41:55ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122017-09-01810.3389/fphar.2017.00689264120Addressing the Challenges of Tuberculosis: A Brief Historical AccountHussam W. Al-Humadi0Hussam W. Al-Humadi1Rafal J. Al-Saigh2Ahmed W. Al-Humadi3Department of Pharmacology and Toxicology, Pharmacy College, University of Babylon, Babylon, IraqLaboratory of Pharmacology, Medical School, National and Kapodistrian University of Athens, Athens, GreeceDepartment of Pharmacology and Toxicology, Pharmacy College, University of Babylon, Babylon, IraqLaboratory of Pharmacology, Medical School, National and Kapodistrian University of Athens, Athens, GreeceTuberculosis (TB) is a highly contagious disease that still poses a threat to human health. Mycobacterium tuberculosis (MTB), the pathogen responsible for TB, uses diverse ways in order to survive in a variety of host lesions and to subsequently evade immune surveillance; as a result, fighting TB and its associated multidrug resistance has been an ongoing challenge. The aim of this review article is to summarize the historical sequence of drug development and use in the fight against TB, with a particular emphasis on the decades between World War II and the dawn of the twenty first century (2000).http://journal.frontiersin.org/article/10.3389/fphar.2017.00689/fulltuberculosishistorytreatmentanti-TB drugsmultidrug resistancepharmaceutical innovation
collection DOAJ
language English
format Article
sources DOAJ
author Hussam W. Al-Humadi
Hussam W. Al-Humadi
Rafal J. Al-Saigh
Ahmed W. Al-Humadi
spellingShingle Hussam W. Al-Humadi
Hussam W. Al-Humadi
Rafal J. Al-Saigh
Ahmed W. Al-Humadi
Addressing the Challenges of Tuberculosis: A Brief Historical Account
Frontiers in Pharmacology
tuberculosis
history
treatment
anti-TB drugs
multidrug resistance
pharmaceutical innovation
author_facet Hussam W. Al-Humadi
Hussam W. Al-Humadi
Rafal J. Al-Saigh
Ahmed W. Al-Humadi
author_sort Hussam W. Al-Humadi
title Addressing the Challenges of Tuberculosis: A Brief Historical Account
title_short Addressing the Challenges of Tuberculosis: A Brief Historical Account
title_full Addressing the Challenges of Tuberculosis: A Brief Historical Account
title_fullStr Addressing the Challenges of Tuberculosis: A Brief Historical Account
title_full_unstemmed Addressing the Challenges of Tuberculosis: A Brief Historical Account
title_sort addressing the challenges of tuberculosis: a brief historical account
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2017-09-01
description Tuberculosis (TB) is a highly contagious disease that still poses a threat to human health. Mycobacterium tuberculosis (MTB), the pathogen responsible for TB, uses diverse ways in order to survive in a variety of host lesions and to subsequently evade immune surveillance; as a result, fighting TB and its associated multidrug resistance has been an ongoing challenge. The aim of this review article is to summarize the historical sequence of drug development and use in the fight against TB, with a particular emphasis on the decades between World War II and the dawn of the twenty first century (2000).
topic tuberculosis
history
treatment
anti-TB drugs
multidrug resistance
pharmaceutical innovation
url http://journal.frontiersin.org/article/10.3389/fphar.2017.00689/full
work_keys_str_mv AT hussamwalhumadi addressingthechallengesoftuberculosisabriefhistoricalaccount
AT hussamwalhumadi addressingthechallengesoftuberculosisabriefhistoricalaccount
AT rafaljalsaigh addressingthechallengesoftuberculosisabriefhistoricalaccount
AT ahmedwalhumadi addressingthechallengesoftuberculosisabriefhistoricalaccount
_version_ 1725700214818340864